Atlas Trials

A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents

Clinical trial NCT06863987 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06863987
Sponsor
Shandong New Time Pharmaceutical Co., LTD
Status
ENROLLING_BY_INVITATION
Phase
Phase 3
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2025-02-05
Primary completion
2027-12-01
Enrollment
342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.